SYSTEMIC LUPUS ERYTHEMATOSUS AND CARDIOVASCULAR PATHOLOGY: MODERN INTERPRETATIONS
Keywords:
systemic lupus erythematosus, atherosclerosis, dyslipidemia, risk factorsAbstract
Systemic lupus erythematosus (SLE) - is an immunoinflammatory rheumatic disease that leads to progressive damage to internal organs, resulting in decreased quality of life and severe consequences. A number of studies have confirmed that cardiovascular complications caused by atherosclerotic vascular lesions lead to a decrease in life expectancy in systemic diseases.
References
Akhil A., Bansal R., Anupam K., Tandon A., Bhatnagar A. Systemic lupus erythematosus: Latest insight into etiopathogenesis // Rheumatol. Int. 2023;43:1381–1393.
Aripova N.A., Djurayeva E.R., Ganiyeva N.A., Ziyayeva F.K., Isakova M.B. Tizimli sklerodermiyaning turli kechish variantlarida interleykin-4 darajasini baholash // Toshkent tibbiyot akademiyasi axborotnomasi. –2023. – №5. – B.25-29.
Ganiyeva N.A., Rizamukhamedova M.Z., Nabiyeva D.A., Aripova N.A. Clinic - diagnostic aspects of modern biomarkers ofearly atherosclerosis and fibrotic activity of systemic scleroderma // Asian Journal of Medical Principles and Clinical Practice. – 2021. - № 4(3). – Р. 1-13.
Guillot M., Rafat C., Buob D., et al. Eculizumab for catastrophic antiphospholipid syndrome – a case report and literature review // Rheumatology (Oxford). 2018;57(11):2055-7.
Lightstone L., Doria A., Wilson H., et al. Can we manage lupus nephritis without chronic corticosteroids administration? Independent association of glucocorticoids with damage accrual in SLE // Autoimmun Rev. 2018;17(1):4-10.
Miñano S., González-Correa C., Moleón J., Duarte J. Metabolic Modulators in Cardiovascular Complications of Systemic Lupus Erythematosus // Biomedicines. 2023 Nov 25;11(12):3142.
Nabiyeva D.A. Dyslipidaemia and Cytokine Profile in patients wioth Gout: the role of IL-6, IL-18 and hyperurecemia in the development of metabolic disorders // Journal of Advances in Medicine and Medical research.- 2017.- № (23.12.) .- 1-10.
Pulatova Sh., Nabiyeva D., Abduazizova N., Mukhammadiyeva S., Agzamova G., Isayeva B. Clinical and pathogenetic values of disorders of mineral metabolism in ankylosing spondylitis // Philosophical Readings XIII.4. – 2022. – PP. 20-28.
Ruiz-Limon P., Barbarroja N., Perez-Sanchez C., et al. Atherosclerosis and cardiovascular disease in systemic lupus erythematosus: effects of in vivo statin treatment // Ann Rheum Dis. 2015;74(7):1450-8.
Szabó M.Z., Szodoray P., Kiss E. Dyslipidemia in systemic lupus erythematosus // Immunol Res. 2017 Apr;65(2):543-550.
Trouw L.A., Pickering M.C., Blom A.M. The complement system as a potential therapeutic target in rheumatic disease // Nat Rev Rheumatol. 2017;13(9):538-47.
